|
|
| Morningstar Overall Rating: |
 |
| Total Assets: |
12.64M |
| Category: |
Mid-Cap Growth |
| Total Expense Ratio: |
1.25% |
|
| PERFORMANCE & RISK | 31-Jan-10
| YTD Return: |
-4.77% |
| 5y Avg Return: |
5.12% |
| Rank in Category (ytd): |
762 |
| % Rank in Category (ytd): |
88.91% |
| Beta (3y): |
1.26 |
| Morningstar Risk Rating: |
|
|
| The investment seeks capital appreciation. The fund primarily invests in common stocks of high growth businesses of all market capitalizations. The Advisor invests in companies in any sector or industry that it believes will benefit from innovations and advances in technology. The fund seeks to purchase securities that the Advisor expects could increase in value 100% within four years. |
|
| Fund Profile |
|
Help
0.13 (1.21%) 
Summary
Add BIOIX to Portfolio 
Download Data
